The best biotech stocks right now, ranked.
We score 532 US-listed biotech stocks, re-ranked every trading day. These 25 rank highest on the full factor model right now. Every US-listed stock Twelve Data files under Biotechnology.
Every score is a percentile across the whole US universe we cover — a 92 beats 92% of it. How the model was built and blind-tested is on the methodology page; what each factor means is on the factor glossary.
| Ticker | Company | Mkt cap | Rank | 1w rank Δ | Revisions | Value | Momentum | Quality | Accruals | Issuance | Growth | Volatility | Size |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AnaptysBio, Inc. Biotechnology | $1.7B | 99.9 | 0.0 | 65.6 | 98.4 | 84.2 | 97.3 | 91.9 | 97.0 | 92.2 | 85.4 | 38.3 | |
Jazz Pharmaceuticals Plc Biotechnology | $15.4B | 99.6 | 0.0 | 81.8 | 98.7 | 92.8 | 84.8 | 79.1 | 82.4 | 93.8 | 98.7 | 12.1 | |
Puma Biotechnology, Inc. Biotechnology | $449.4M | 98.6 | +0.5 | 64.9 | 99.8 | 95.8 | 98.5 | 75.7 | 84.8 | 30.0 | 91.0 | 55.3 | |
Exelixis, Inc. Biotechnology | $13.3B | 98.0 | +0.3 | 62.3 | 99.6 | 67.0 | 98.1 | 82.2 | 95.0 | 75.3 | 96.3 | 13.3 | |
Prothena Corp. Plc Biotechnology | $476.9M | 97.7 | −0.7 | 79.3 | 86.9 | 53.9 | 72.0 | 43.7 | 91.9 | 99.7 | 90.3 | 54.5 | |
Zevra Therapeutics, Inc. Biotechnology | $664.6M | 97.0 | −0.6 | 88.1 | 98.4 | 50.5 | 98.8 | 24.6 | 73.2 | 92.4 | 75.9 | 50.4 | |
Protagonist Therapeutics, Inc. Biotechnology | $9.9B | 96.9 | −0.7 | 76.0 | 93.8 | 95.5 | 83.4 | 67.2 | 54.0 | 83.6 | 98.4 | 16.2 | |
Fortrea Holdings, Inc. Biotechnology | $1.6B | 96.6 | +0.1 | 76.3 | 84.0 | 84.0 | 60.9 | 95.2 | 76.9 | 93.6 | 9.5 | 38.8 | |
Halozyme Therapeutics, Inc. Biotechnology | $11.2B | 96.4 | −0.6 | 89.7 | 98.9 | 76.4 | 98.8 | 65.7 | 45.7 | 67.4 | 96.7 | 14.9 | |
Arbutus Biopharma Corp. Biotechnology | $919.7M | 96.3 | −2.6 | 74.7 | 96.2 | 77.5 | 97.2 | 18.3 | 58.3 | 99.3 | 89.1 | 46.5 | |
MediciNova, Inc. Biotechnology | $64.4M | 96.0 | +6.7 | 79.2 | 52.7 | 57.2 | 59.7 | 69.8 | 76.5 | 89.2 | 87.8 | 80.0 | |
Aurinia Pharmaceuticals, Inc. Biotechnology | $2.1B | 95.7 | −0.5 | 60.7 | 99.3 | 79.1 | 96.5 | 21.3 | 91.3 | 81.9 | 97.1 | 36.2 | |
Prelude Therapeutics, Inc. Biotechnology | $524.7M | 95.7 | −0.5 | 76.2 | 86.6 | 99.2 | 67.4 | 77.5 | 37.8 | 94.3 | 29.1 | 53.3 | |
Fate Therapeutics, Inc. Biotechnology | $298.8M | 94.9 | +1.5 | 74.3 | 58.6 | 83.7 | 65.7 | 81.3 | 71.7 | 94.1 | 20.3 | 62.3 | |
Vericel Corp. Biotechnology | $2.2B | 94.8 | +0.6 | 83.5 | 58.9 | 65.0 | 96.0 | 73.8 | 72.0 | 80.7 | 63.0 | 35.1 | |
ImmuCell Corp. Biotechnology | $90.9M | 94.0 | −2.0 | 25.0 | 73.3 | 88.1 | 95.3 | 96.2 | 80.2 | 39.1 | 94.0 | 76.3 | |
Bio-Techne Corp. Biotechnology | $11.3B | 93.9 | +2.6 | 66.8 | 81.5 | 86.6 | 77.0 | 72.7 | 89.4 | 65.9 | 88.1 | 14.9 | |
Vir Biotechnology, Inc. Biotechnology | $1.6B | 93.1 | +0.1 | 64.3 | 87.3 | 78.0 | 85.5 | 47.1 | 49.3 | 99.4 | 87.6 | 39.6 | |
OmniAb, Inc. Biotechnology | $486.6M | 93.0 | +0.1 | 88.4 | 66.8 | 61.2 | 61.1 | 81.3 | 51.8 | 96.5 | 40.6 | 54.1 | |
Regeneron Pharmaceuticals, Inc. Biotechnology | $84.4B | 91.8 | +0.4 | 92.5 | 94.6 | 72.8 | 82.8 | 38.7 | 78.4 | 62.8 | 94.3 | 3.4 | |
Septerna, Inc. Biotechnology | $2.0B | 91.4 | +13.9 | 75.5 | 75.1 | 92.2 | 60.8 | 89.6 | 42.0 | 90.5 | 35.0 | 36.6 | |
Iovance Biotherapeutics, Inc. Biotechnology | $3.1B | 90.5 | +1.7 | 84.3 | 87.4 | 85.7 | 94.0 | 44.0 | 43.4 | 84.7 | 33.3 | 30.6 | |
Omeros Corp. Biotechnology | $1.2B | 89.8 | +18.1 | 97.9 | 67.6 | 88.4 | 77.9 | 31.8 | 76.4 | 74.3 | 7.6 | 43.4 | |
Incyte Corp. Biotechnology | $24.0B | 89.8 | +0.3 | 45.8 | 98.6 | 84.7 | 96.8 | 45.6 | 71.7 | 85.4 | 98.5 | 9.4 | |
Maravai Lifesciences Holdings, Inc. Biotechnology | $1.5B | 89.4 | +3.3 | 76.7 | 43.3 | 90.1 | 37.3 | 86.6 | 83.3 | 95.3 | 33.2 | 40.6 |
Today’s snapshot only — the list rotates as the scores move. Click any ticker for its full page: rank against every factor, analyst price targets, financials and news.
What these biotech stocks look like up close.
Figures for the 25 listed names, from the same data behind their stock pages.
16 of the 24 names with analyst coverage this month carry a Buy-or-better majority.
Cheapest on trailing P/E: ABUS at 5.9×, AUPH at 6.7× and OMER at 10.4×.
Highest forward dividend yields: PRTA at 2.3%, REGN at 0.5% and TECH at 0.4%.
Where we've written the stock up.
An analyst-style read on the business behind the score — published on the stock page.
This page is one list. Monday covers the whole market.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks and the factor behind each one. The names above will rotate as the scores move — the Radar is how you hear what changed.
Questions people ask about biotech stocks.
- What are the best biotech stocks right now?
- As at 15 Aug 2026, the top-ranked biotech stocks on Ticker Nerd's systematic factor model are AnaptysBio, Inc. (ANAB), Jazz Pharmaceuticals Plc (JAZZ), Puma Biotechnology, Inc. (PBYI). The full top 25 is the table on this page, re-ranked every trading day. A rank is general information, not personal advice.
- How does Ticker Nerd pick the best biotech stocks?
- Nobody picks them. A factor model scores roughly 4,600 US stocks every trading day on families like value, momentum, quality and growth, and this page is one fixed cut of that ranking. The research process behind the model — point-in-time data from 2005, locked test windows, logged rejections — is published on the methodology page.
- Are biotech stocks a good investment?
- That depends on the price paid and on your circumstances — this page is general information, not advice. What the data says as at 15 Aug 2026: of the 24 listed names with analyst coverage this month, 16 carry a Buy-or-better majority, and every rank above is a percentile across roughly 4,600 US stocks.
The same model, other cuts.
Every list reads the one ranking — the stock screener index has the complete set.